German pharmaceutical firm Boehringer Ingelheim has selected Certara's D360 as its global drug discovery platform, which will help in sharing discovery data across global working groups that can include external collaborators. Certara is ...
Danish pharmaceutical firm Novo Nordisk has received biologics licence application (BLA) approval from the US Food and Drug Administration (FDA) for its recombinant coagulation factor VIII, Novoeight. Novoeight is intended for adults and ...
Tags: Novo Nordisk, Drug
US-based specialty pharmaceutical firm Par Pharmaceutical has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for clonidine hydrochloride (HCl) extended-release (ER) ...
Tags: Par Pharmaceutical, Medicine
Japanese pharmaceutical firm PeptiDream and France-based Ipsen have expanded their research collaboration and license option agreement signed in April 2013 to develop peptide drugs to treat serious endocrinologic disease. The deal has now ...
Tags: PeptiDream, Ipsen, peptide drugs
Japanese pharmaceutical firm Eisai has secured approval from the European Commission (EC) on the license extension application for the use of antiepileptic agent Zonegran (zonisamide) in the treatment of pediatric patients. The EC ...
Tags: Eisai Obtains, Zonegran
Biopharmaceutical contract manufacturer Sigma-Tau PharmaSource has entered into a manufacturing services agreement with Aradigm, a specialty pharmaceutical firm focused on the development and commercialization of drugs delivered by ...
Activaero has entered into research collaboration with Italian pharmaceutical firm Chiesi Farmaceutici to develop an effective solution to treat patients with cystic fibrosis (CF). Under the deal, Activaero will offer its flow and volume ...
US-based specialty pharmaceutical firm Upsher-Smith Laboratories will launch the generic version of its Morphine Sulfate extended-release (ER) capsules, CII on 4 September 2013. Morphine Sulfate ER Capsules, CII are currently available in ...
Tags: ER Capsules, pharmaceutical
Xi'an Janssen Pharmaceutical Ltd., the biggest subsidiary of US healthcare giant Johnson & Johnson in the Chinese mainland, is expected to see days be harder in the future. It was established by Janssen-Cilag, a subsidiary of Jonson & ...
Japanese pharmaceutical firm Eisai Co, through its South Korean marketing subsidiary, has rolled out a higher-dose, once-daily Aricept (donepezil hydrochloride) 23mg tablet formulation used to treat moderate-to-severe Alzheimer's disease ...
Tags: pharmaceutical firm, Medicine
Pharmaceutical firm Merck reported a net income of $906m, or $0.30 per share for the second quarter ended on 30 June 2013 compared to $1.8bn, or $0.58 per share in 2012. Total revenue for the second quarter ended on 30 June 2013 was ...
Tags: Merck, Pharmaceutical firm
Viennese biotech company Marinomed Biotechnologie has licensed the rights of five drugs to a global pharmaceutical firm for the Chinese market. The drugs include three antiviral nasal sprays against common cold, influenza and colds in ...
This is especially true of organizations subject to compliance with regulations like PCI-DSS or HIPAA, but any organization could find itself in trouble if it can't get its hands on emails and SMS messages during an ediscovery process. ...
Tags: IT, HIPAA, forensic investigations, mobile devices
Pharmaceutical firm Merck has reported a 4% decline in its net sales in the third quarter 2012 to $11.5bn, as against $12.02bn for the same quarter in 2011. The firm's GAAP net income for the third quarter declined to $1.79bn, down from ...
Tags: Pharmaceutical firm Merck, Merck's pharmaceutical sales
An IT recruitment expert has criticised government pay thresholds for overseas IT workers in the UK, claiming it groups vastly different jobs together and sets salaries too low, presuming an IT director in the UK can earn as little as ...
Tags: IT workers, MAC, IT professionals, low-cost IT staff